The Antiseptics and Disinfectants market is expected to rise due to Rising Incidence of Hospital-Acquired Infections, Growing Geriatric Population and Subsequent Growth in the Prevalence of Chronic Diseases, and Increasing Number of Surgical Procedures
The hospital acquired infections are not just prevalent in developing countries, but in developed countries as well. As per CDC's National Healthcare Safety Network (NHSN) Surgical Site Infection Surveillance in 2018, it is estimated that 11% of all deaths in intensive care units are associated with surgical site infections. This has lead to increasing demand for antiseptics and disinfectants in hospitals and clinics. As a result of these factors, the market is expected to grow.
Key Market Trends
Application as Surface Disinfectants is Expected to Rise over the Forecast Period
Surface Disinfectants are chemical agents designed to inactivate or destroy microorganisms on inert surfaces. These Disinfectants work by destroying the cell wall of microbes or interfering with their metabolism. Using proper surface disinfection can prevent infections that develop during hospitalization, which are neither present nor incubating at the time of a patient's admission. There are a variety of chemicals used in surface disinfectants for different purposes.
The demand for disinfectants has increased in the market, due to the increasing number of hospital visits. For instance, the number of visits to the accident and emergency department (A&E) has increased continuously over the years in England. As per the 2020 report by the National Health Service, attendance has risen from 59,396 in 2013 to 70,230 in 2019. As a result, the demand surface disinfectants has also increased, which has resulted in market growth.
North America is Expected to Dominate the Market
The North American region is expected to dominate the market primarily due to factors such as the large presence of key market players and a well-developed healthcare system in the United States.
As per a 2020 report by the American Hospital Association (AHA), in 2017, hospitals recorded a total of 880.5 million outpatient visits and in 2018, those same hospitals delivered 879.6 million outpatient visits. This has resulted in increased demand for antiseptics and disinfectants in the hospitals.
Additionally, as per a 2018 report Mainul Haquw, published in Journal of Infection and Drug Resistance, nearly 1.7 million hospitalized patients annually acquire hospital care acquired infections (HCAI)s while being treated for other health issues and that more than 98,000 of these patients (1 in 17) die due to HCAIs. Moreover, the above-mentioned report also states that HCAIs are the most common complications of hospital care in the US.
These factors have resulted in high demand for antiseptics and disinfectants in the United States.
Majority of the Antiseptics and Disinfectants products are being manufactured by the global key players. Market leaders with more funds for research and better distribution system have established their position in the market. Moreover, Asia-pacific is witnessing an emergence of some small players due to the rise of awareness. This has also helped the Antiseptics and Disinfectants market grow.
- The market estimate (ME) sheet in Excel format
- 3 months of analyst support
This product will be delivered within 2 business days.
Table of Contents
1.2 Scope of the Study
4.2 Market Drivers
4.2.1 Rising Incidence of Hospital-Acquired Infections
4.2.2 Growing Geriatric Population and Subsequent Growth in the Prevalence of Chronic Diseases
4.2.3 Increasing Number of Surgical Procedures
4.3 Market Restraints
4.3.1 Issues Related to the Sterilization and Disinfection of Advanced Medical Instruments
4.3.2 Side Effects of Certain Toxic Substances
4.4 Porter's Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5.1.1 Quaternary Ammonium Compounds
5.1.2 Chlorine Compounds
5.1.3 Alcohols & Aldehyde Products
5.2 By Application
5.2.1 Enzymatic Cleaners
5.2.2 Medical Device Disinfectants
5.2.3 Surface Disinfectants
5.2.4 Other Applications
5.3 By End User
5.3.1 Hospitals and Clinics
5.3.3 Other End Users
5.4.1 North America
220.127.116.11 United States
18.104.22.168 United Kingdom
22.214.171.124 Rest of Europe
126.96.36.199 South Korea
188.8.131.52 Rest of Asia-Pacific
5.4.4 Middle East & Africa
184.108.40.206 South Africa
220.127.116.11 Rest of Middle East & Africa
5.4.5 South America
18.104.22.168 Rest of South America
6.1.1 3M Company
6.1.2 Cantel Medical Corporation
6.1.3 Becton, Dickinson and Company
6.1.4 Procter and Gamble
6.1.5 SC Johnson Professional
6.1.6 Steris Corporation
6.1.7 The Clorox Company
6.1.8 Reckitt Benckiser Group plc
6.1.9 Steris PLC
A selection of companies mentioned in this report includes:
- 3M Company
- Cantel Medical Corporation
- Becton, Dickinson and Company
- Procter and Gamble
- SC Johnson Professional
- Steris Corporation
- The Clorox Company
- Reckitt Benckiser Group plc
- Steris PLC